Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
Read Article
News
2024
2023
Archive
Search news articles
November 30, 2020
Aprea Therapeutics Receives FDA Fast Track Designation for Eprenetapopt in the Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
November 19, 2020
Vor Biopharma Promotes Tirtha Chakraborty to Chief Scientific Officer
November 19, 2020
Pear Therapeutics and Health Transformation Alliance Join in Providing Access for reSET® and reSET-O® to Self-Insured Employers
November 17, 2020
Pear Therapeutics Launches Somryst™ for Chronic Insomnia Via an End-To-End Virtual Care Experience
November 12, 2020
ChristianaCare Teams with Pear Therapeutics to Bring Patients Access to New Therapeutic Class of FDA-Authorized Prescription Digital Therapeutics for Treatment of Substance Use Disorders
November 11, 2020
Vor Biopharma Announces Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer Institute
November 10, 2020
Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study
November 9, 2020
Impel Neuropharma Announces FDA Submission of New Drug Application for INP104 for the Acute Treatment of Migraine
November 9, 2020
Homology Medicines Announces $60 Million Equity Investment from Pfizer Inc.
November 6, 2020
Artiva & Affimed Announce Platform-to-Platform R&D Collaboration for Off-the-Shelf NK Cell Therapies
« Previous Page
1
…
47
48
49
50
51
…
118
Next Page »